Condition
Human Papilloma Virus clinical trials and research
As of November 12, 2026, Find a Trial lists 18 Human Papilloma Virus clinical trials that are recruiting, at sites in 10 countries (most in United States (9), Belgium (3), Canada (2)). By phase: Phase 2 (4), Phase 4 (2), Phase 1 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 18Clinical trials
- 10Countries
Newest Human Papilloma Virus clinical trials
All recruiting trials (18)
-
HPV self-sampling in the ED to screen under-screened women
This study tests whether giving an HPV self-sampling kit in the emergency department can help under-screened women get screened for cervical cancer and find those with HPV to guide follow-up care.
-
CHW4CervixHealth: HPV self-collection kits with community health workers
This project will test whether giving self-collection HPV kits during community workshops led by community health workers helps increase screening among under-screened women aged 25–65 and will first compare kit results to clinical Pap smears.
-
Preventing cervical cancer with rapid HPV genotyping and same-day self-sampling
This project tests whether a rapid HPV genotyping test on self-collected and provider-collected samples can quickly identify women at high risk so they can receive same-day screening and treatment in low-resource settings.
-
Lidocaine injection before surgery for oropharyngeal cancer
This study tests if giving a lidocaine injection before surgery can help improve outcomes for patients with oropharyngeal cancer.
-
High resolution anal examination for HPV and anal cancer detection
This study is testing how well high-resolution anal exams can help find high-risk HPV and anal cancer in people who are more likely to have these issues.
-
Evaluating the Gardasil HPV vaccine's immune responses in people with and without HIV
This study is testing how well the Gardasil HPV vaccine works in people born male, both with and without HIV, to see how their immune systems respond to the vaccine.
-
Developing a new test for cervical cancer using self-collected samples
This study is testing a new way to screen for cervical cancer using self-collected urine and vaginal samples to see if it works better than traditional methods.
-
Improving access to HPV vaccination and self‑swab screening for women with experience of homelessness, substance use, incarceration, or transactional sex in Scotland
This project will try offering Gardasil‑9 vaccination and a self‑taken HPV swab to women aged 25–45 in Scotland who have experienced homelessness, substance use, incarceration, or transactional sex to see if uptake and feasibility improve.
-
Understanding oropharyngeal carcinoma and its connection to HPV
This study is trying to learn more about oropharyngeal cancer and its link to HPV by collecting blood samples from patients to see how the disease changes over time.
-
Monitoring anal health in women with a history of high-grade HPV lesions
This study is trying to see if regular check-ups can help women with a history of high-grade HPV lesions catch any signs of anal cancer early.
-
Reduced dosing of the HPV vaccine for women living with HIV
This study is testing if a lower dose of the HPV vaccine can effectively protect women living with HIV from HPV and cervical cancer.
-
Lower radiation therapy combined with standard chemotherapy for HPV-positive throat cancer
This study is testing whether using less radiation therapy along with standard chemotherapy can help people with HPV-positive throat cancer feel better while causing fewer side effects.
-
Using Candida antigen and a bivalent HPV vaccine to clear multiple common warts
This study will test whether injections of Candida antigen, a bivalent HPV vaccine, or both can clear multiple common warts in people with persistent or widespread warts.
-
HPV screening for women aged 23-29
This study tests if using HPV screening can better protect women aged 23-29 from cervical cancer compared to the usual method of checking cells.
-
Pembrolizumab plus lenvatinib for HPV-related recurrent respiratory papillomatosis with lung involvement
This research will try pembrolizumab together with lenvatinib in adults who have HPV-associated recurrent respiratory papillomatosis that involves the lungs.
-
Improving HPV vaccine uptake in underserved populations
This study is trying to see if educational workshops can help young people in underserved communities understand the importance of the HPV vaccine and encourage them to get vaccinated.
-
Treatment for clearing genital HR-HPV infections using 2LPAPI®
This study is testing if a new immune treatment called 2LPAPI® can help women aged 25 to 45 clear high-risk HPV infections more effectively than a placebo.
-
Short-course radiation therapy for oropharynx cancer
This study is testing a shorter and more targeted radiation treatment for people with HPV-related throat cancer to see if it can reduce side effects while still being effective.
Related topics
Quick answers
How many Human Papilloma Virus clinical trials are recruiting right now?
18, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 10 countries. The most sites are in United States (9 trials), Belgium (3 trials), Canada (2 trials), Romania (1 trial), Sweden (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 4, Phase 4: 2, Phase 1: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.